Поисковый запрос: (<.>S=ИРИНОТЕКАН<.>) |
Общее количество найденных документов : 359
Показаны документы с 1 по 20
|
|
1.
| A case of irinotecan-induced pneumonitis // Haigan, 2000. Vol. 40, N 3.-С.219-221
|
2.
| A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-'альфа' inhibitor // J. Pharmacol. and Exp. Ther., 2006. Vol. 319, N 1.-С.82-104
|
3.
| A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-'альфа' inhibitor // J. Pharmacol. and Exp. Ther., 2006. Vol. 319, N 1.-С.82-104
|
4.
| A multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer // Cancer Chemother. and Pharmacol., 2011. Vol. 68, N 1.-С.63-68
|
5.
| A new metabolite of irinotecan (CPT-11) whose formation in mediated by human hepatic cytochrome P-450 3A4 // Drug Metab. Rev., 2001. Vol. 33, прил. N 1.-С.127
|
6.
| A novel combination of cisplatin, irinotecan, and capecitabine in patients with advanced cancer // Invest. New Drugs, 2004. Vol. 22, N 2.-С.185-192
|
7.
| A phase I study of irinotecan in combination with amrubicin for advanced lung cancer patients // Anticancer Res., 2006. Vol. 26, N 3B.-С.2479-2485
|
8.
| A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital // Clin. Pharmacol. and Ther., 2004. Vol. 76, N 5.-С.490-502
|
9.
| A phase II study with CPT-11 plus leucovorin and bolus IV 5-fluorouracil in patients with advanced colorectal carcinoma // Cancer Invest., 2003. Vol. 21, N 6.-С.855-862
|
10.
| A phase II study with CPT-11 plus leucovorin and bolus IV 5-fluorouracil in patients with advanced colorectal carcinoma // Cancer Invest., 2003. Vol. 21, N 6.-С.855-862
|
11.
| A phase II trial of cisplatin and irinotecan in patients with advanced esophageal cancer // Cancer Invest., 1999. Vol. 17, Suppl. n1.-С.26
|
12.
| A phase II trial of cisplatin and irinotecan in patients with advanced esophageal cancer // Cancer Invest., 1999. Vol. 17, Suppl. n1.-С.26
|
13.
| A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors // Dig. Diseases and Sci., 2006. Vol. 51, N 6.-С.1033-1038
|
14.
| A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors // Dig. Diseases and Sci., 2006. Vol. 51, N 6.-С.1033-1038
|
15.
| A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinoma // Dig. Diseases and Sci., 2005. Vol. 50, N 12.-С.2218-2223
|
16.
| A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinoma // Dig. Diseases and Sci., 2005. Vol. 50, N 12.-С.2218-2223
|
17.
| A phase II trial of weekly irinotecan in cisplatin-refractory esophageal cancer // Anticancer Res., 2007. Vol. 27, N 4C.-С.2845-2848
|
18.
| A pilot study of salvage irinotecan monotherapy for advanced biliary tract cancer // Anticancer Res., 2013. Vol. 33, N 6.-С.2619-2622
|
19.
| A prospective randomized study of irinotecan (CPT-11), leucovorin (LV) and 5-fluorouracil (5FU) versus leucovorin and 5-fluorouracil in patients with advanced colorectal carcinoma // J. Chemother., 2006. Vol. 18, N 5.-С.538-544
|
20.
| ABCG2 inhibitor YHO-13351 sensitizes cancer stem/initiating-like side population cells to irinotecan // Anticancer Res., 2013. Vol. 33, N 4.-С.1379-1386
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"